Atlas Trials

Study of Plasma Tumor-promoting Factors and Immune Function After Laparotomy, Cytoreductive Surgery and HIPEC vs. PIPAC in Patients With Peritoneal Metastasis

Clinical trial NCT04122885 · UNKNOWN

Trial details

NCT number
NCT04122885
Sponsor
University Hospital Tuebingen
Status
UNKNOWN
Study type
OBSERVATIONAL
Peritoneal CancerChemotherapy-Induced Change
Start date
2019-10-01
Primary completion
2020-09-30
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.